Adam M. Veness
SVP, General Counsel and Sec. · Dianthus Therapeutics, Inc. /DE/
- 2026
- Aug 14, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Adam M. Veness files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marino Garcia - $27.96M in DNTH purchases and sales in the last 12 months
- Simrat Randhawa - $15.00M in DNTH purchases and sales in the last 12 months
- Ryan Savitz - $14.29M in DNTH purchases and sales in the last 12 months
- Edward Carr - $5.59M in DNTH purchases and sales in the last 12 months
- Paula Soteropoulos - $2.25M in DNTH purchases and sales in the last 12 months
- Anne McGeorge - $845K in DNTH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Adam M. Veness?
Adam M. Veness is a corporate insider, tracked as SVP, General Counsel and Sec. of Dianthus Therapeutics, Inc. /DE/ (DNTH). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Adam M. Veness submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Adam M. Veness been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($4.63M) across all tracked filings.
